Chapter 146 Good news for 3900 million AIDS patients!

The injection process is to use an IV drip to transmit the 'RNP complex' of the EBT-002 gene therapy drug to cells throughout the body through the blood vessels.

During the whole process, the human body will experience various negative reactions, and abnormal phenomena such as pain, numbness, itching, fever, chills, coma, etc. may occur.

The medical staff of Liancheng People's Hospital have also made full preparations and are ready to provide emergency rescue to the three clinical trial participants in case of any accidents.

Time passed by bit by bit, and as the EBT-002 gene medical drug began to flow, the battle at the cellular genetic level was in full swing.

Just like that, in just over ten minutes, the EBT-002 gene medical drug was completely injected.

The next injections are regular injections of glucose and other substances to replenish cellular energy consumption.

Seeing this, netizens also patiently waited for the latest results. Although some netizens left halfway, they would come back from time to time to check the latest situation.

As for the domestic and foreign reporters at the scene, they were unlucky. They had to wait for the latest results on the spot.

But in the whole process, it actually seems quite boring.

Because apart from fever, chills, and occasional coughing, these three people did not encounter any special conditions that required emergency rescue.

Time passed by little by little, and in the blink of an eye it was the third day.

On this day, after a physical examination in the morning, they will receive a second injection of the EBT-002 gene therapy drug.

As for whether the third injection is needed?

The need to inject a third bottle of EBT-002 gene therapy drug will be determined based on the test results after the second injection.

After all, in theory, after two injections, the HIV virus in the body should be completely eliminated.

If the test shows that there is no HIV virus in the body, the injection of the third bottle of EBT-002 gene therapy drug can be stopped.

Of course, if you have money and want to continue the injection, that's fine. After all, abnormal reactions to the injection are acceptable, and more injections provide an extra layer of safety.

However, the only headache is the money issue. For a bottle of EBT-002 gene medical drug, Xingtu Gene Company quoted a price of summer yuan per bottle.

The cost of three bottles of medicine, plus the cost of physical examination and gene sequencing matching and hospitalization, the entire process will definitely start at 4 yuan.

Of course, if only two bottles of EBT-002 gene medical drug are needed for injection, the starting price would be only about 3 yuan.

In addition, because of medical insurance reimbursement, the actual cost is definitely not that much.

After all, as long as you think about it, you will know that such a miraculous drug will definitely be included in the medical insurance drug list of various countries. In the end, with medical insurance reimbursement, you only need to pay a part of the money.

But netizens don’t care about so many things, nor do they think about how much they actually need to spend after medical insurance reimbursement.

At this time, when they look at the extremely high price of EBT-002 gene medical drug, some people will naturally think it is expensive.

I think that Xingtu Gene Company is simply robbing people by charging 002 Xia Yuan for a bottle of EBT- gene medical drug.

After all, a bottle of EBT-002 gene medical drug was priced at summer yuan, which did seem too exaggerated.

So they questioned the rationality of the price and thought that Raymond Lam was a vampire.

In response, Xingtu Gene Company directly gave a rough report on capital expenditure.

In this rough report on capital expenditure, people also saw the terrifying speed at which Xingtu Gene Company was burning money.

Among them, 200 billion Xia Yuan and 32 billion US dollars of funds for the construction of gene research and development laboratories are extremely dazzling. After that, other scientific research and development expenditures are also very shocking, which makes people see the determination of Xingtu Gene Company to spend money on research and development.

Finally, Raymond Lam also posted on Weibo and Twitter that in the next ten years, none of the money earned by Star Path Genetics will be used for dividends.

The parent company, Xingtu Technology, will not take the initiative to withdraw money from its subsidiary, Xingtu Gene.

Because Raymond Lam said that all the money earned by Star Path Genetics will be used to explore the mysteries of human genes and the genes of all things, and to solve human diseases within ten years!

Faced with Lin Feng's words, those who thought that the EBT-002 gene medical drug was too expensive could not help but shut their mouths.

After all, Lin Feng claimed that he would not distribute dividends for ten years, and all the money he earned in the past ten years was invested in scientific research and development.

This is to speed up the progress of scientific research and development and solve human diseases. What do you mean by calling Lin Feng a vampire at this time?
And if we look around the world, is there any company or any boss who dares to give up such huge profits and money like Lin Feng?

But Lin Feng did it. Under such circumstances, it would be unreasonable to criticize Xingtu Gene Company for selling expensive drugs and to call Lin Feng a vampire.

Of course, there will definitely be people who curse, and this cannot be stopped, no matter whether the price of the EBT-002 gene medical drug is yuan or or yuan.

After all, the manufacturing cost of EBT-002 gene medical drug is indeed there, and the average cost of a bottle of this stuff is several hundred yuan.

After all, it uses chemical synthesis methods, which not only requires expensive equipment and extremely high raw material requirements, but the entire manufacturing process also requires hundreds of procedures and is extremely cumbersome.

Finally, the drug must be injected immediately after production, otherwise the efficacy of the drug will gradually decrease over time.

The accumulation of various shortcomings means that the price of this thing will not be much cheaper, plus tax costs, R&D costs and other costs.

The final selling price must be more than 2000 yuan, otherwise it would be sold at a very low price. Once the price exceeds 2000 yuan, it will naturally be criticized.

But since it is going to be criticized, Xingtu Gene Company will naturally offer a higher price and earn more profit so that it can use the money for scientific research and development, rather than selling at a rock-bottom price.

Of course, ten thousand yuan a bottle is actually not expensive.

Don’t they know about the hepatitis C drug Xiafaning developed by the American company Gilead?

The price of each tablet of this thing in the United States is 7820 yuan. The movie "Dying to Survive" tells the story of this super expensive drug!
China is a country with a high incidence of hepatitis, with approximately 4500 million hepatitis C patients nationwide. One can imagine how much money Gilead makes.

So compared to the American pharmaceutical companies, Starway Genetics is a true angel.

After all, the use of EBT-002 gene medical drug can not only directly solve the problem of HIV, but also provide immunity in the future.

As for this point, Xingtu Technology will naturally publicize it, and the effect of publicity is very good.

Everything is afraid of comparison. With Gilead as an example, the price of EBT-002 gene medical drug of Xingtu Gene Company seems very reasonable.

Therefore, regarding the extremely high price of EBT-002 gene medical drug, most people accept and acknowledge the rationality of this price.

And time continued to pass, and in the blink of an eye, a few days passed, and it was the 002th day of the clinical trial of the EBT-7 gene medical drug.

On this day, the three clinical trial personnel underwent a unified physical examination early in the morning and then in the afternoon.

Xingtu Gene Company and Daxia Medical Institution jointly announced that the world's three clinical trials of EBT-002 gene medical drugs have achieved great success.

After the physical examination on the morning of the seventh day, it was found that the HIV virus was no longer present in the bodies of the three AIDS patients!

(End of this chapter)